DK3638293T3 - Sammensætninger til behandling af cancer - Google Patents
Sammensætninger til behandling af cancer Download PDFInfo
- Publication number
- DK3638293T3 DK3638293T3 DK18817894.1T DK18817894T DK3638293T3 DK 3638293 T3 DK3638293 T3 DK 3638293T3 DK 18817894 T DK18817894 T DK 18817894T DK 3638293 T3 DK3638293 T3 DK 3638293T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- compositions
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/26—Endoribonucleases producing 5'-phosphomonoesters (3.1.26)
- C12Y301/26003—Ribonuclease III (3.1.26.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21037—Leukocyte elastase (3.4.21.37), i.e. neutrophil-elastase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520325P | 2017-06-15 | 2017-06-15 | |
| US201762610711P | 2017-12-27 | 2017-12-27 | |
| PCT/US2018/037800 WO2018232273A1 (en) | 2017-06-15 | 2018-06-15 | Methods and compositions for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3638293T3 true DK3638293T3 (da) | 2023-11-06 |
| DK3638293T5 DK3638293T5 (da) | 2024-08-26 |
Family
ID=64659547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18817894.1T DK3638293T5 (da) | 2017-06-15 | 2018-06-15 | Sammensætninger til behandling af cancer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210299234A1 (da) |
| EP (2) | EP3638293B1 (da) |
| JP (3) | JP7189160B2 (da) |
| CN (1) | CN111032075A (da) |
| AU (1) | AU2018285710B2 (da) |
| CA (1) | CA3066738A1 (da) |
| DK (1) | DK3638293T5 (da) |
| ES (1) | ES2962985T3 (da) |
| WO (1) | WO2018232273A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119015448A (zh) * | 2018-12-20 | 2024-11-26 | 芝加哥大学 | 与用于癌症疗法的治疗肽相关的方法和组合物 |
| CN116261592A (zh) * | 2020-08-18 | 2023-06-13 | 昂希莱斯制药公司 | 经修饰的丝氨酸蛋白酶前蛋白 |
| JP2023545346A (ja) * | 2020-08-18 | 2023-10-30 | オンチレス・ファーマ・インコーポレイテッド | 改変ブタ膵臓エラスターゼタンパク質 |
| CN112812150A (zh) * | 2021-01-29 | 2021-05-18 | 深圳海创生物科技有限公司 | 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用 |
| CN113736742B (zh) * | 2021-09-08 | 2023-07-21 | 河南省医药科学研究院 | Prtn3基因作为肿瘤免疫治疗中激活细胞毒性免疫细胞靶点的应用 |
| CN115040642B (zh) * | 2022-06-30 | 2025-03-28 | 德博尔(成都)生物科技有限公司 | 一种胰弹性蛋白酶的新用途 |
| CN118443941A (zh) * | 2024-04-29 | 2024-08-06 | 山东大学齐鲁医院 | 中性粒细胞作为诊疗膀胱癌的靶标的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| BR9106732A (pt) * | 1990-08-03 | 1993-08-17 | Vertex Pharma | Processo catalisado por enzima para preparar um produto selecionado,processos para produzir aspartame,imobilizar uma enzima e imobilizar termolisina,cristais de enzima e de termolisina imobilizadas reticuladas,dispositivos que compreendem as mesmas e biossensor para detectar um analito de interesse em um fluido |
| US5698518A (en) * | 1994-03-30 | 1997-12-16 | Oklahoma Medical Research Foundation | Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists |
| AU2003231981A1 (en) * | 2002-03-29 | 2003-10-13 | Incyte Corporation | Protein modification and maintenance molecules |
| WO2004031237A1 (en) | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human myeloid leukemia |
| JP4408615B2 (ja) | 2002-10-07 | 2010-02-03 | 独立行政法人科学技術振興機構 | 好酸球カチオン性タンパク質を含有する組成物 |
| US8068990B2 (en) * | 2003-03-25 | 2011-11-29 | Hologic, Inc. | Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids |
| EP2003196A3 (en) * | 2003-06-09 | 2009-01-07 | The Regents of the University of Michigan | Compositions and methods for treating and diagnosing cancer |
| ES2316997T3 (es) * | 2003-07-21 | 2009-04-16 | F. Hoffmann-La Roche Ag | Uso de la proteina proteinasa 3 (prn3) y del inhibidor de la elastasa leucocitaria (ileu) como un marcador para el cancer colorrectal. |
| US7432419B2 (en) * | 2004-05-14 | 2008-10-07 | Los Alamos National Security, Llc | Compositions and methods for the treatment of Pierce's disease |
| US20060008891A1 (en) * | 2004-06-23 | 2006-01-12 | The Government Of Usa As Repersented By The Secretary, Department Of Health And Human Services | Cathepsin G-related peptides as modulators of formylpeptide receptors (FPR) |
| US8501449B2 (en) * | 2007-12-04 | 2013-08-06 | Proteon Therapeutics, Inc. | Recombinant elastase proteins and methods of manufacturing and use thereof |
| CN102165075A (zh) * | 2008-07-18 | 2011-08-24 | 奥洁克公司 | 用于检测和治疗结肠直肠癌的组合物 |
| GB201121070D0 (en) | 2011-12-07 | 2012-01-18 | Isis Innovation | composition for delivery of biotherapeutics |
| WO2016125330A1 (ja) | 2015-02-02 | 2016-08-11 | 原 英彰 | 網膜再生促進薬 |
-
2018
- 2018-06-15 US US16/621,549 patent/US20210299234A1/en active Pending
- 2018-06-15 EP EP18817894.1A patent/EP3638293B1/en active Active
- 2018-06-15 AU AU2018285710A patent/AU2018285710B2/en active Active
- 2018-06-15 JP JP2019569454A patent/JP7189160B2/ja active Active
- 2018-06-15 EP EP23191473.0A patent/EP4292606B1/en active Active
- 2018-06-15 CA CA3066738A patent/CA3066738A1/en active Pending
- 2018-06-15 CN CN201880053084.1A patent/CN111032075A/zh active Pending
- 2018-06-15 DK DK18817894.1T patent/DK3638293T5/da active
- 2018-06-15 WO PCT/US2018/037800 patent/WO2018232273A1/en not_active Ceased
- 2018-06-15 ES ES18817894T patent/ES2962985T3/es active Active
-
2022
- 2022-12-01 JP JP2022192891A patent/JP7529754B2/ja active Active
-
2024
- 2024-07-25 JP JP2024119305A patent/JP2024150679A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210299234A1 (en) | 2021-09-30 |
| JP2020524141A (ja) | 2020-08-13 |
| EP3638293A1 (en) | 2020-04-22 |
| JP2023022242A (ja) | 2023-02-14 |
| EP4292606A3 (en) | 2024-02-21 |
| CN111032075A (zh) | 2020-04-17 |
| EP4292606B1 (en) | 2025-11-12 |
| JP7529754B2 (ja) | 2024-08-06 |
| ES2962985T3 (es) | 2024-03-22 |
| EP3638293B1 (en) | 2023-10-04 |
| EP3638293A4 (en) | 2021-03-10 |
| CA3066738A1 (en) | 2018-12-20 |
| WO2018232273A1 (en) | 2018-12-20 |
| AU2018285710A1 (en) | 2020-01-23 |
| JP2024150679A (ja) | 2024-10-23 |
| AU2018285710B2 (en) | 2025-02-13 |
| JP7189160B2 (ja) | 2022-12-13 |
| EP4292606A2 (en) | 2023-12-20 |
| DK3638293T5 (da) | 2024-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3431105T3 (da) | Medicinsk sammensætning til behandling af cancer | |
| DK3570844T3 (da) | Azolopyrimidin til behandlingen af kræftrelaterede lidelser | |
| DK3377516T3 (da) | Sammensætning til behandling af cancer | |
| DK3439635T3 (da) | Formuleringer til behandling af fast tumor | |
| DK3288581T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK3728271T3 (da) | Makrocykliske forbindelser til behandling af sygdomme | |
| DK3474841T3 (da) | Fremgangsmåder til behandling af ar+-brystkræft | |
| DK3173092T3 (da) | Rna-holdig sammensætning til behandling af tumorsygdomme | |
| DK3189082T3 (da) | Anti-pd-l1-konjugater til behandling af tumorer | |
| DK3612215T3 (da) | Sammensætninger til behandling af lungeinflammation | |
| DK3785733T3 (da) | Farmaceutisk sammensætning til behandling af autisme | |
| DK3277270T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| DK3524255T3 (da) | Sammensætning til behandling af acne | |
| DK3458052T3 (da) | Kombinationsbehandling af cancer | |
| DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
| DK3081263T3 (da) | Sammensætninger og redskaber til behandling af glaukom | |
| DK3638293T3 (da) | Sammensætninger til behandling af cancer | |
| DK3400072T3 (da) | Formuleringer til behandling af blærecancer | |
| DK4101454T3 (da) | Sammensætninger til behandling af hypertension | |
| DK3468604T3 (da) | Farmaceutiske kombinationer til behandling af cancer | |
| DK3377094T3 (da) | Virulenssvækkede bakterier til behandling af ondartede solide tumorer | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3478284T3 (da) | Forbindelser og sammensætninger til behandling af cancer |